Literature DB >> 20959964

Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy.

K Amrein1, H P Dimai, H Dobnig, A Fahrleitner-Pammer.   

Abstract

We report the case of a 36-year-old woman who developed permanent hypoparathyroidism after thyroidectomy for differentiated thyroid carcinoma. A 6-year follow-up showed an increase of 11% in absolute bone mineral density at the spine and 6% at the hip accompanied by low bone turnover despite thyroid-stimulating hormone suppressive thyroxine therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959964     DOI: 10.1007/s00198-010-1441-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  19 in total

Review 1.  [Complications in thyroid surgery. Incidence and therapy].

Authors:  H D Röher; P E Goretzki; P Hellmann; J Witte
Journal:  Chirurg       Date:  1999-09       Impact factor: 0.955

Review 2.  [Identification of the recurrent laryngeal nerve and parathyroids in thyroid surgery].

Authors:  H Dralle
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

3.  Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy.

Authors:  Elias E Mazokopakis; Ioannis K Starakis; Maria G Papadomanolaki; Antony G Batistakis; John A Papadakis
Journal:  Curr Med Res Opin       Date:  2006-07       Impact factor: 2.580

4.  Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women.

Authors:  Elaine Murphy; Claus C Glüer; David M Reid; Dieter Felsenberg; Christian Roux; Richard Eastell; Graham R Williams
Journal:  J Clin Endocrinol Metab       Date:  2010-04-21       Impact factor: 5.958

5.  Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.

Authors:  Karen K Winer; Chia Wen Ko; James C Reynolds; Karen Dowdy; Meg Keil; Donna Peterson; Lynn H Gerber; Charles McGarvey; Gordon B Cutler
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

6.  Increased bone mineral density in patients with chronic hypoparathyroidism.

Authors:  Fredriech K W Chan; Sau-Cheung Tiu; Kin-Lam Choi; Cheung-Hei Choi; Alice P S Kong; Chi-Chung Shek
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

7.  Therapy of hypoparathyroidism with intact parathyroid hormone.

Authors:  M R Rubin; J Sliney; D J McMahon; S J Silverberg; J P Bilezikian
Journal:  Osteoporos Int       Date:  2010-01-22       Impact factor: 4.507

8.  Dynamic and structural properties of the skeleton in hypoparathyroidism.

Authors:  Mishaela R Rubin; David W Dempster; Hua Zhou; Elizabeth Shane; Thomas Nickolas; James Sliney; Shonni J Silverberg; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

Review 9.  Hypoparathyroidism after total thyroidectomy.

Authors:  M Testini; A Gurrado; G Lissidini; M Nacchiero
Journal:  Minerva Chir       Date:  2007-10       Impact factor: 1.000

10.  Bone mineral density in patients with chronic hypoparathyroidism.

Authors:  S Abugassa; J Nordenström; S Eriksson; G Sjödén
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

View more
  1 in total

Review 1.  A lifetime of hypercalcemia and hypercalciuria, finally explained.

Authors:  Thomas P Jacobs; Martin Kaufman; Glenville Jones; Rajiv Kumar; Karl-Peter Schlingmann; Sue Shapses; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-01-13       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.